Eastern Bank’s Amicus Therapeutics FOLD Stock Holding History

Eastern Bank’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-525	Closed	-$7.59K	–	1091
2026 Q1	$7.59K	Hold	525	–	–	﹤0.01%	883
2025 Q4	$7.48K	Buy	+525	New	+$5.16K	﹤0.01%	918

Eastern Bank's FOLD Position: Q2 2026 in Review

Eastern Bank sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 525 shares — an estimated $7.59K sold.

Eastern Bank first reported a position in FOLD in Q4 2025 and held it in 2 quarters. The position peaked at $7.59K in Q1 2026. 0 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

Eastern Bank reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
Eastern Bank sold 525 Amicus Therapeutics shares in Q2 2026, an estimated $7.59K.
Eastern Bank first reported a position in Amicus Therapeutics in Q4 2025 and held it in 2 quarters.
Eastern Bank's Amicus Therapeutics position peaked at $7.59K in Q1 2026.
0 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Eastern Bank's 13F filing for Q2 2026, filed 1 Jul 2026.